Section Arrow
Quote
ITCI.NASDAQ
- Intra-Cellular Therapies
Quotes are at least 15-min delayed:2025/02/23 06:43 EST
Last
 128.6
+0.06 (+0.05%)
Day High 
128.77 
Prev. Close
128.54 
1-M High
128.77 
Volume 
1.26M 
Bid
128.4
Ask
128.6
Day Low
128.52 
Open
128.77 
1-M Low
126.43 
Market Cap 
13.67B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 127.78 
20-SMA 127.43 
50-SMA 107.65 
52-W High 128.77 
52-W Low 63.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.87/5.79
Enterprise Value
13.68B
Balance Sheet
Book Value Per Share
10.77
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
462.18M
Operating Revenue Per Share
3.93
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 06:43 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.